Wagner P, Heinecke J W
Department of Internal Medicine, Washington University School of Medicine, St Louis, Mo., USA.
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3338-46. doi: 10.1161/01.atv.17.11.3338.
Oxidized LDL is implicated in the pathogenesis of atherosclerosis. A widely studied model for oxidation of the lipid in LDL involves Cu2+. Recent studies suggest that Cu2+ may be reduced to Cu1+ by alpha-tocopherol to initiate LDL lipid peroxidation. LDL demonstrates binding sites for Cu2-, but the nature of these binding sites, as well their role in promoting Cu2+ reduction and lipid peroxidation, has not been established. In the current studies, we used diethylpyrocarbonate (DEPC) to modify the histidine residues of apolipoprotein B100, the major protein in LDL. First, we demonstrated that histidine residues were preferentially modified by DEPC under our experimental conditions. Then we monitored the kinetics of Cu(2+)-promoted oxidation of LDL and DEPC-modified LDL. In both cases, the progress curve of lipid peroxidation exhibited a lag phase and a propagation phase. However, when LDL was modified with DEPC, the length of the lag phase was prolonged whereas the rate of lipid peroxidation during the propagation phase was lower. Studies with LDL oxidized by 2,2'-azobis (2-amidinopropane) hydrochloride and phosphatidylcholine liposomes oxidized with hydroxyl radical established that DEPC was not acting simply as a nonspecific inhibitor of lipid peroxidation. DEPC treatment of LDL almost completely inhibited its ability to bind Cu2+. These observations suggest that peroxidation of the lipids in LDL can proceed with normal kinetics only when Cu2+ binds preferentially to sites on apolipoprotein B100 that contain histidine residues. We also compared the kinetics of Cu2+ reduction in the absence and presence of DEPC. There was no effect of DEPC modification on either the rate or extent of Cu2+ reduction by LDL. Therefore LDL is likely to contain a second class of binding sites for Cu2+ that does not involve histidine residues. Thus, LDL appears to contain at least two classes of Cu(2+)-binding sites: histidine containing sites, which are responsible in part for promoting lipid peroxidation during the propagation phase, and sites at which Cu2+ is reduced without binding to histidine.
氧化型低密度脂蛋白(Oxidized LDL)与动脉粥样硬化的发病机制有关。一个被广泛研究的低密度脂蛋白脂质氧化模型涉及铜离子(Cu2+)。最近的研究表明,α-生育酚可能会将Cu2+还原为Cu1+,从而引发低密度脂蛋白脂质过氧化。低密度脂蛋白显示出对Cu2-的结合位点,但这些结合位点的性质以及它们在促进Cu2+还原和脂质过氧化中的作用尚未确定。在当前的研究中,我们使用焦碳酸二乙酯(DEPC)来修饰低密度脂蛋白中主要蛋白质载脂蛋白B100的组氨酸残基。首先,我们证明在我们的实验条件下组氨酸残基优先被DEPC修饰。然后我们监测了Cu(2+)促进的低密度脂蛋白和DEPC修饰的低密度脂蛋白氧化的动力学。在这两种情况下,脂质过氧化的进程曲线都呈现出一个滞后期和一个增殖期。然而,当低密度脂蛋白用DEPC修饰时,滞后期的长度延长,而增殖期脂质过氧化的速率较低。用盐酸2,2'-偶氮双(2-脒基丙烷)氧化的低密度脂蛋白和用羟基自由基氧化的磷脂酰胆碱脂质体的研究表明,DEPC并非仅仅作为脂质过氧化的非特异性抑制剂起作用。DEPC处理低密度脂蛋白几乎完全抑制了其结合Cu2+的能力。这些观察结果表明,只有当Cu2+优先结合到载脂蛋白B100上含有组氨酸残基的位点时,低密度脂蛋白中的脂质过氧化才能以正常的动力学进行。我们还比较了在有无DEPC存在的情况下Cu2+还原的动力学。DEPC修饰对低密度脂蛋白还原Cu2+的速率或程度均无影响。因此,低密度脂蛋白可能含有另一类不涉及组氨酸残基的Cu2+结合位点。因此,低密度脂蛋白似乎至少含有两类Cu(2+)结合位点:含组氨酸的位点,其在增殖期部分负责促进脂质过氧化;以及Cu2+在不与组氨酸结合的情况下被还原的位点。